Evidence map›Paper›PMID 12411579›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Presentation of antagonist peptides to naive CD4+ T cells abrogates spatial reorganization of class II MHC peptide complexes on the surface of dendritic cells.

Bartosz Chmielowski, Rafal Pacholczyk, Piotr Kraj, Pawel Kisielow, Leszek Ignatowicz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Bartosz ChmielowskiInstitute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta 30912, USA.
Rafal Pacholczyk
Piotr Kraj
Pawel Kisielow
Leszek Ignatowicz
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

Antigen biased positive selection of CD4+ T cellsR01HD036302 · NICHD · MEDICAL COLLEGE OF GEORGIA (MCG) · PI IGNATOWICZ, LESZEK · 1997 to 2006
$1.4M
Positive selection of TCR by class II MHC/PeptideR01AI041145 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI IGNATOWICZ, LESZEK · 1998 to 2007
$1.4M
NIAID NIH HHS AI41145-01A1NIAID NIH HHS R01 AI041145NICHD NIH HHS HD36302-02NICHD NIH HHS R01 HD036302
6 · The paper itself

Abstract

By using dendritic cells (DCs) transduced with retroviruses encoding covalent A(b)beta/peptide fusion proteins tagged with fluorescent proteins, we followed the relocation of class II MHC molecules loaded with agonist or null peptides during the onset of activation of naive and effector CD4(+) T cells. Clusters of T cell receptor (TCR)/CD3 complex formed in parallel with clusters of agonist class II MHC/peptide complexes on the surface of DCs. However, activation of naive but not effector T cells was accompanied by expulsion of the null class II MHC/peptide complexes from the T cell-DC interface. These effects were perturbed in the presence of exogenously supplied antagonist peptide. These results suggest that interference with selective relocation of agonist and null MHC/peptide complexes in the immunological synapse contributes to the inhibitory effect of antagonist peptides on the response of naive CD4(+) T cells to agonist ligands.

Indexed as

Amino Acid SequenceAnimalsAntigens, Differentiation, B-LymphocyteBacterial ProteinsBiological TransportBone Marrow CellsCalciumCD8-Positive T-LymphocytesColumbidaeCytochrome c GroupDendritic CellsFlow CytometryHistocompatibility Antigens Class IIKineticsLuminescent ProteinsLymph NodesAntigens, Differentiation, B-LymphocyteBacterial ProteinsCalciumCytochrome c GroupHistocompatibility Antigens Class IIinvariant chainLuminescent ProteinsOligopeptidesyellow fluorescent protein, Bacteria

Identifiers

PMID12411579
PMCPMC137536
OpenAlexW2058468156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.